| Primary |
| Product Used For Unknown Indication |
53.7% |
| Dyspepsia |
10.5% |
| Hypertension |
5.1% |
| Gastrooesophageal Reflux Disease |
4.8% |
| Mineral Supplementation |
4.4% |
| Osteoporosis Postmenopausal |
3.2% |
| Hypocalcaemia |
2.8% |
| Osteoporosis |
2.2% |
| Osteoporosis Prophylaxis |
2.0% |
| Hypoparathyroidism |
1.4% |
| Hypothyroidism |
1.4% |
| Drug Use For Unknown Indication |
1.2% |
| Abdominal Discomfort |
1.0% |
| Medical Diet |
1.0% |
| Prophylaxis |
1.0% |
| Abdominal Distension |
0.8% |
| Blood Cholesterol Abnormal |
0.8% |
| Blood Cholesterol Increased |
0.8% |
| Diabetes Mellitus |
0.8% |
| Hyperphosphataemia |
0.8% |
|
| Drug Dependence |
52.9% |
| Dependence |
11.9% |
| Milk-alkali Syndrome |
8.7% |
| Nephrolithiasis |
4.2% |
| Intentional Drug Misuse |
3.2% |
| Product Quality Issue |
2.2% |
| Renal Failure Acute |
1.9% |
| Vomiting |
1.9% |
| Drug Administration Error |
1.6% |
| Choking |
1.3% |
| Nephrocalcinosis |
1.3% |
| Polyuria |
1.3% |
| Calciphylaxis |
1.0% |
| Drug Abuser |
1.0% |
| Drug Interaction |
1.0% |
| Hypercalcaemia |
1.0% |
| Hypocalcaemia |
1.0% |
| Incorrect Dose Administered |
1.0% |
| Incorrect Route Of Drug Administration |
1.0% |
| Intentional Overdose |
1.0% |
|
| Secondary |
| Product Used For Unknown Indication |
39.5% |
| Hypertension |
13.1% |
| Osteoporosis Postmenopausal |
9.9% |
| Drug Use For Unknown Indication |
4.9% |
| Osteoporosis |
4.6% |
| Prophylaxis |
4.3% |
| Diabetes Mellitus |
2.9% |
| Hyperphosphataemia |
2.8% |
| Rheumatoid Arthritis |
2.5% |
| Hypoparathyroidism |
2.0% |
| Dyspepsia |
1.7% |
| Hypothyroidism |
1.6% |
| Foetal Exposure During Pregnancy |
1.5% |
| Hypocalcaemia |
1.5% |
| Medical Diet |
1.3% |
| Routine Health Maintenance |
1.3% |
| Osteoarthritis |
1.3% |
| Asthma |
1.2% |
| Chronic Obstructive Pulmonary Disease |
1.1% |
| Depression |
1.1% |
|
| Drug Dispensing Error |
15.3% |
| Renal Failure |
6.6% |
| Vomiting |
6.6% |
| Drug Rash With Eosinophilia And Systemic Symptoms |
5.6% |
| Swelling Face |
5.6% |
| Milk-alkali Syndrome |
5.1% |
| Drug Ineffective |
4.6% |
| Nausea |
4.6% |
| Thrombocytopenia |
4.6% |
| Hypercalcaemia |
4.1% |
| Mental Disorder |
4.1% |
| Myocardial Infarction |
4.1% |
| Renal Failure Chronic |
4.1% |
| Diarrhoea |
3.6% |
| Drug Interaction |
3.6% |
| Polyuria |
3.6% |
| Pulmonary Embolism |
3.6% |
| Sepsis |
3.6% |
| Stress |
3.6% |
| Weight Decreased |
3.6% |
|
| Concomitant |
| Product Used For Unknown Indication |
34.1% |
| Drug Use For Unknown Indication |
17.2% |
| Osteoporosis |
8.0% |
| Rheumatoid Arthritis |
7.1% |
| Hypertension |
6.8% |
| Pain |
3.7% |
| Prophylaxis |
3.4% |
| Crohn's Disease |
2.4% |
| Gastrooesophageal Reflux Disease |
1.9% |
| Multiple Myeloma |
1.9% |
| Supplementation Therapy |
1.8% |
| Depression |
1.7% |
| Hyperphosphataemia |
1.4% |
| Constipation |
1.4% |
| Diabetes Mellitus |
1.4% |
| Atrial Fibrillation |
1.3% |
| Nausea |
1.3% |
| Vitamin Supplementation |
1.2% |
| Mineral Supplementation |
1.1% |
| Anxiety |
1.1% |
|
| Vomiting |
13.3% |
| Pyrexia |
6.7% |
| Nausea |
6.5% |
| Urinary Tract Infection |
6.4% |
| Pneumonia |
6.1% |
| Weight Decreased |
6.1% |
| Death |
6.0% |
| Pain |
5.5% |
| Dyspnoea |
4.6% |
| Fall |
4.5% |
| Pain In Extremity |
4.0% |
| Fatigue |
3.6% |
| Pulmonary Embolism |
3.6% |
| Drug Ineffective |
3.5% |
| Sepsis |
3.5% |
| Diarrhoea |
3.4% |
| Arthralgia |
3.2% |
| Dizziness |
3.2% |
| Thrombocytopenia |
3.2% |
| Headache |
3.1% |
|
| Interacting |
| Product Used For Unknown Indication |
52.1% |
| Dyspnoea |
8.0% |
| Gastric Disorder |
3.1% |
| Obsessive-compulsive Disorder |
3.1% |
| Renal Failure Chronic |
3.1% |
| Blood Pressure High |
2.5% |
| Contraception |
2.5% |
| Depression |
2.5% |
| Fatigue |
2.5% |
| Insomnia |
2.5% |
| Onychomycosis |
2.5% |
| Osteopenia |
2.5% |
| Osteoporosis |
2.5% |
| Raynaud's Phenomenon |
2.5% |
| Smoking Cessation Therapy |
1.8% |
| Vulvovaginal Candidiasis |
1.8% |
| Arthritis |
1.2% |
| Crohn's Disease |
1.2% |
| Multiple Sclerosis |
1.2% |
| Nervous System Disorder |
1.2% |
|
| Drug Interaction |
20.0% |
| Cerebrovascular Accident |
8.0% |
| Abasia |
4.0% |
| Abnormal Weight Gain |
4.0% |
| Arthralgia |
4.0% |
| Condition Aggravated |
4.0% |
| Dementia |
4.0% |
| Feeling Abnormal |
4.0% |
| Gastrointestinal Infection |
4.0% |
| Hot Flush |
4.0% |
| Lupus-like Syndrome |
4.0% |
| Neutropenia |
4.0% |
| Pain In Extremity |
4.0% |
| Rash |
4.0% |
| Rash Erythematous |
4.0% |
| Skin Odour Abnormal |
4.0% |
| Speech Disorder |
4.0% |
| Therapeutic Response Decreased |
4.0% |
| Transaminases Increased |
4.0% |
| Vomiting |
4.0% |
|
